Guggenheim Capital LLC Shockwave Medical, Inc. Transaction History

Guggenheim Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$191.17 - $325.63 $745,371 - $1.27 Million	3,899 New	3,899 $1.27 Million
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $116,015 - $169,530	597 Added 10.67%	6,194 $1.23 Million
Q2 2023 Aug 11, 2023	SELL	$223.05 - $302.68 $168,848 - $229,128	-757 Reduced 11.91%	5,597 $1.6 Million
Q1 2023 May 10, 2023	SELL	$175.41 - $217.92 $359,765 - $446,953	-2,051 Reduced 24.4%	6,354 $1.38 Million
Q4 2022 Feb 14, 2023	SELL	$204.38 - $296.82 $1.08 Million - $1.57 Million	-5,288 Reduced 38.62%	8,405 $1.73 Million
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $288,910 - $459,584	1,480 Added 12.12%	13,693 $3.81 Million
Q2 2022 Aug 15, 2022	BUY	$115.91 - $214.48 $1.42 Million - $2.62 Million	12,213 New	12,213 $2.34 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.